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ABSTRACT
Central Nervous System Toxicity of Alpha-Chaconine in Rats
by
Charles Newell Aldous
Utah State

III~

Master of Science

University~

1979

Major Professor: Dr. R. P. Sharma
Department: Toxicology
Effects of alpha-chaconine were examined in the central nervous
system on the basis of electrophysiological tests and by assaying for
changes in the levels of several known neurotransmitters of the brain.
The possibility that brain acetylcholine levels might increase correspending to acetylcholinesterase
gated~

i~hibition

in treated rats was investi-

where an increase would suggest that the anti-acetylcholinesterase

activity of alpha-chaconine was physiologically significant.
Various doses of alpha-chaconine were given to rats prepared for
physiological tests.

Some symptoms were observed at relatively low

doses (8 to 10 milligrams per ki logram) .
of abdominal

muscles~

respiratory

These included constriction

impairment~

and sedation.

At the

same dosage the electroencephalogram pattern was altered by a notable
increase in the low-frequency component.

Tachycardia was observed at

both low (10 mill ig rams per kil ogram) and at high doses (40 milligrams
per

k ilogram)~

whereas intermediate doses (20 to 30 milligrams per

kil ogram ) were associated with bradycardia.
Although other physiological tests implicated the brain as the
target organ, analyses of brain neurotransmitter chemicals failed to

ix
show significant trends.

Compounds assayed were acetylcholine, nore-

pinephrine, dopamine, serotonin, and the serotonin metabolite, 5hydroxyindoleacetic acid.

The observation that acetylcholine levels

were unchanged after alpha-chaconine administration did not support
the hypothesis that the major toxic effect of the test compound was
caused by alterations in the levels of this neurotransmitter.
(76 pages)

INTRODUCTION
Human mortality due to the ingestion of the tubers or other parts
of the domestic potato, Solanwn tuoeroswn L., is a rare event.

t~ ost

human poisonings involved the use of potato shoots (Willimott, 1933),
potatoes which had turned green upon exposure to the sun (Hansen,
1925), or tubers unusually high in solanidine glycoalkaloids.
About 95 percent of the glycoalkaloids in Solanwn tuberosum L.
consist of a-chaconine and a- solanine, the balance being sugar hydrolysis products of the two compounds (Wood, 1976). _Alpha-solanine consists of a solanidine molecule to which galactose, glucose and
rhamnose are attached as shown in Figure l.

The same figure shows

a- chaconine, which is identical to a-solanine except that the attached
sugars are one glucose unit and two rhamnose units per aglycon molecule.

Because important studies have been made on a-chaconine, a-

solanine and on mixtures of the two compounds (usually under the generic
name "sola nine " or under "total glycoalkaloid"), cross-comparisons
would be useful if they could be justified.

Nishie et al. (1975)

found no essential differences between a-chaconine and a-solanine
effects on rabbit electroencephalogram (EEG) , electrocardiogram (ECG),
respiration or blood pressure recordings.

Because a-chaconine is the

more abundant glycoalkaloid in tubers (Herb et al., 1975) and because
fecal and urinary excretion are more severely impaired by a-chaconine
than by a-solanine (Nishie et al., 1975), a-chaconine was selected as
the test compound for central nervous system (CNS) toxicity studies.

2

CH3
I
I
I

H

0

HO

"~o~

~
OH OH

0<-

SOLANINE

CH3
I
I
I

H

HO~
CH3
°
HO
OH

OH

Figu re 1.

I

H

0

~0~

~
OH OH

ex- CHACONINE

Struct ura l formu l as of a-so lanine and a-chaconine .

3

Concern that solanidine glycoalkaloids might affect cholinergic
function originated when Orgell et al. (1958) analyzed potato plants
for cholinesterase (ChE) inhibition associated v1ith pesticide residues,
and were surprised to find such inhibition in the absence of agricultural chemicals.

Evidence that CNS. anti-acetylcholinesterase effects

were attributable to solanidine glycoalkaloids was obtained by Nishie
et al. (1971) and by Patil et al. (1972).

Subsequent proof of brain

acetylcholinesterase (AChE) inhibition in vitro as well as in vivo was
reported by Alozie (1977).
The solanidine glycoalkaloids cause a complex of symptoms.
primary organ affected is presumably the heart.

A

Alpha-chacon i ne and

a-solanine are among the more potent cardiac glycosides derived from
plants of Solanaqeae species in terms of the amount required to elicit
a positive inotropic effect in frog heart preparations (Nishie et al.,
1976).

Lethal doses of solanidine glycoalkaloids are often associated

with tac hycardia in man and animals (Willimott, 1933; Nishie et al.,
1971).

Inflammation of the alimentary tract has been reported in man

(RUhl, 1950; Willimott, 1933).

Hemor rhag ic ascites were reported in

rats given intraperitoneal (ip) injections of a- solanine (Nishie et al.,
1971; Chaube and Swinyard, 1976).

Considerable interest in the solanidine compounds arose from the
hypothesis of Renwick (1972), in which he implicated blighted potatoes
and the associated solanidine to be the cause of an unusual increase in
the incidence of the congenital defects of the brain and spinal column,
anencephaly and spina bifida.

Subsequent experiments have not found

solanidine to be teratogenic (Brown et al., 1978).
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The major toxic effects of the solanidine glycoalkaloids after
ip injection are associated with the heart and the CNS.

The studies

reported here investigated the CNS as the primary target for achaconine toxicity.

Special emphasis was given to effects on the con-

centrations of brain neurotransmitter chemicals, particularly acetylcholine (ACh), since changes in the levels of these compounds are often
associated with abnormal synthesis, storage, release, or metabolism of
neurotransmitters.

Rat brain ACh levels were measured to determine

whether or not the AChE inhibition reported by Alozie (1977) was sufficient to alter ACh levels in the brain.

Concentrations of other

neurotransmitter amines such as norepinephrine (NE), dopamine (DA),
and serotonin (5-HT) have been observed to change in response to organochlorine pesticides (Hrdina, 1973; Sharma, 1973) which also affect
ACh levels.

Assays of these biogenic amines and of the serotonin

metabolite, 5-hydroxyindoleacetic acid (5-HIAA), were performed to
find possible effects on non-cholinergic systems.

Electroencephalo-

grams (EEGs) \vere recorded to observe excitatory or depressant effects
as man ifes ted in the electrical activity of the cortex.

The EEGs

were contrasted wi th those of organophosphate AChE inhibitors, which
caus e EEG excitement at low levels and depression at high levels of
the drugs (Rieger, 1975; Hyde et al., 1978).

Alpha-chaconine doses

were chosen which were below levels that markedly compromise cardiac
function so th at statistically significant findings or unusual observations would not be attributable to cardiovascular embarrassment.
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REVIEW OF LITERATURE
To xic constituents of potatoes
Recent reviews on stress metabolites of the Irish potato (solanum
tubero s um L.) have been written by Wood (1976) and Kuc (1973).

They

considered normal constituents of tubers such as chlorogenic and caffeic
acids, scopolin and scopoletin, as well as some compounds elicited by
fungal infection, including rishitin, phytuberin, and related compounds.

These ·non-g l ycoalkaloidal compounds appear or increase upon

inf ection of the tubers with such f ungi as Phytophthora infestans .
About 95 percent of the glyco alk aloids in potatoes are a-solanine and
a-chaconine, the balance being parti ally hyd rolyzed products of those
t wo compounds (Wood, 1976) .

Glycoalkaloid synthesis is inhibited by

infections, but increases in response to mechanical injury (Wood, 1976),
light, and temperature (Salunkhe et al., 1972).

The glycoalkaloids

offer some protection to the plants and plant parts of Solanaceae
species against microbial and insect pests.

The fungitoxicity of

solanine was the basis of a bioassay by Patil et al. (1972) employing
Trichode rma viride .
acetat~

The wild potato plant, Solanum chacoens e~ has an

group attached to the solanidine moiety of a-solanine and a-

chaconine molecules, constituting leptine II and leptine I, respectively (Zitnak, 1968).

Leptine I effectively protects plant parts from

being eaten by potato beetle larvae (Kuhn and Low, 1961).

The lep-

tines are apparently not found in appreciable amounts in So l anum
t uberosum L. tubers, as they were not reported by Herb et al. (1975)

in gas chromatographic analyses of potato glycoalkaloids.
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Alpha-solanine and a-chaconine are the compounds of normal potatoes which constitute a significant hazard to human health (Wood,
1976).

Alpha-chaconine is the more abundant of the two glycoalkaloids

in potatoes (Herb et al., 1975).

These compounds can be extracted

into dilute acetic acid (Gull and }senberg, 1960) or into polar solvent
systems such as methanol-chloroform (2:1) (Herb et al., 1975).

If an

acetic acid extract is heated after raising the pH to 9 with ammonium
hydroxide, the solanidine glycoalkaloids precipitate and can be removed by centrifugation (Gull and Isenberg, 1960).

The pellet can be

recrystallized in ethanol as a mixture of a-solanine and a-chaconine.
When separation is desired, it is accomplished chromatographically
with alumina or silica gel (Kuhn and L6w, 1961; R6nsch and Schreiber,
1966; Zitnak, 1968).
Human toxicity
Incidents of potato toxicity to humans are few because pe ople
avoid potatoes which are green or bitter tasting due to high glycoalkaloid content.

Willimott (1933) reported an unusual practice of

eating young potato shoots in certain districts of Cyprus.

One family

partook of a meal including potato shoots, and all members of the
family suffered to some extent.
hours.

Symptoms were delayed for about 12

They included gastroenteritis, headache, severe colic-like

pains in the stomach and abdomen, fever (38- 40°C), tachycardia (100
to 110 beats per minute), vomiting, nausea, diarrhea with blood and
mucus, great weakness and depression.

Victims experienced breathing

difficulties, drowsiness and general apathy.
vulsions.

One girl suffered con-

Of the family, one died 44 hours after the meal.

All
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others were recovering by the fourth day.

The deceased was a man 52

years of age, who had become semiconscious, somewhat cyanotic, and
was in great pain shortly before his death, which was attributed to
syncope.

On autopsy the stomach and intestinal tract were found to

be inflamed, and his blood was more. fluid than normal.
A similar report was given by RUhl (1951) concerning a fatal
poisoning of a two-year-old girl who had eaten potato blossoms.

She

survived for 13 days and showed many of the signs described by Willimott (1933), such as minor dyspnea, cyanosis, fever, vomiting, and
diarrhea interrupted by temporary constipation.
state of unconsciousness.

Death followed a final

Histological examination indicated sub-

stantial bleeding and inflammation in several areas of the body.
Superficial ulcerations and considerable destruction of the mucous
membranes occurred, especially in the lips, tongue, mouth, and lower
esophagous.

Bleeding occurred in mediastinal tissues.

Hemorrhage

and inflammation were seen in the mucous membrance of the intestinal
tract, especially in the cecum and ascending colon.

Subcutaneous fat

tissues underwent multiple hemorrhages, especially over the shins.
Diffuse fatty liv er degeneration was observed microscopally.
Similar symptoms were reported by Hansen (1925).
dull and apathetic.
diarrhea.

Patients were

All we re constipated except for one who had

Two were restless before the onset of exhaustion prior to

death.
Absorption, distribution, and metabolic
fate of a-solanine and a- chaconine
The studies of Nishie et al. (1971) and of Norred et al. (1976) ·
found that a-solanine and a-chaconine undergo similar distribution and
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fate in the rat.

Oral doses of radioactive glycoalkaloids were ex-

creted predominantly in the feces.

Most of the glycoalkaloid content

was excreted during the first 24 hours by this route.
80 percent of the dose was excreted in the feces.
accounted for 10 percent of the dose.

After 48 hours,

Urinary excretion

Fecal material contained largely

solanidine, but about 25 percent of fecal radioactivity after oral
dosing of a-chaconine was excreted unchanged.

A small fraction of

radioactivity consisted of compounds with chromatographic mobilities
intermediate between the a-glycoalkaloids and solanidine.

These were

presumably products of partial hydrolysis of the sugar units.

Intra-

peritoneal (ip) doses led to greater distribution to tissues and reduced excretion rates of the glycoalkaloids.

With a-solanine, 15 to

20 percent of the dose was excreted in feces, and a similar amount in
urine.

The pattern with ip injections of a-chaconine was slightly

different in that the degree of urinary excretion (14%) was approximately double the fecal excretion in a 24-hour period.

A notable

impairment of excretory mechanisms was observed with both glycoalkaloids.

While a-solanine fecal excretion was significantly reduced

only at the 25 mg/kg level, fecal elimination was virtually halted at
a-ch aconine levels of 15 mg/kg.

Urinary excretion of a-chaconine was

dramatically impaired at 25 mg/kg.

Excretory impairment may account

for much of the enhancement of toxicity of these compounds at high
doses.
Acute toxicity in experimental ani ma ls
The median lethal dose (Lo

) of the mixed potato glycoalkaloid
50
given ip to rats was reported as 75 mg/kg (Gull et al., 1970). Chaube
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and Swinyard (1976) found Lo 50 values for Female rats to be 84 mg/kg
for a-chaconine, 67 mg/kg for a-solanine, and 60 mg/kg for 11 total
glycoalkaloid extract. 11

Mice were more sensitive than rats.

Nishie

et al. (1975) found the Lo

values of a-solanine and a-chaconine to
50
be 34.5 and 32.3 mg/kg (statistica1ly equal) in mice. Rabbit LD 50
values were not computed, but appear to be intermediate between those
for the two rodents.

Due to the poor absorption of the glycoalkaloids,

the oral LD

values are much higher than for the ip route. Gull et
50
al. (1970) determined the LD
in rats to be 590 mg/kg after oral
50
dosing. Nishie et al . (1971) reported a 1000 mg/kg oral dose of asolanine to be nonlethal to mice.

A summary of acute toxicity data

related to Solanum tuberosum L. and its glycoalkaloids is given by
Jadhav and Salunkhe (1975).
Pharmacolog ical effects
Nishie et al. (1971) performed a series of pharmacological tests
with a-solan i ne on laboratory

animal~.

A 30 mg/kg dose given ip to a

rabbit markedly increased both respiratory rate and heart rate.

In-

creased heart rate is contrary to the anti-ChE effect and suggests
either a direct or CNS-mediated effect of this organ .

The heart con-

tinued to beat rapidly until the animal became cyanotic a few minutes
before death.

Cyanosis was concommitant with low frequency (delta)

activity in all EEG leads.

The investigators concluded that death

resulted from CNS depression, since the EEG signals disappeared before
respiration ceased.

Respiration and EEG tracings suggested the pos-

sibility that brain failure was due to respiratory failure, since
delta waves did not appear until cyanosis was apparent.

They surmised
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that the delta activity was caused by high intracranial pressure, but
they did not report any measurements of pressure in their study.
Other results of the study suggested a CNS effect of a-solanine.
The spontaneous motor activity of mice was reduced by ip doses as low
as 10 mg/kg.
mice.

Twenty mg/kg increased the pentobarbital sleping time of

Alpha-solanine caused contraction of guinea pig ileum strips at

levels of 50 to 100 micrograms/ml, suggestive of anti-ChE activity.
Anti-acetylcholinesterase activity
Orgell et al. (1958) found anti-AChE activity in potato plants
which were free of pesticide residues.

Later Orgell (1963) reported

marked ChE inhibition by such Solanum glycoalkaloids as a- solanine,
tomatine, and leptine I.

Harris and Whittaker (1962) found that a-

solanine and solanidine inhibited differentially the serum cholinesterases of three human phenotypes in the same manner as the local
anesthetic, dibucaine.

Inhibition of ChE in the three serum types was
80, 63, and 20 percent in response to 10- 5 ~d ibucaine. Alpha-solanine

was about four times more potent than dibucaine, and solanidine was
slightly less potent than a-solanine.

Such phenotypic differences were

not observed wi th the organophosphate AChE inhibitors used in research
and agriculture.
Patil et al. (1972) found weak to moderate inhibition of serum
and erythrocyte ChE activity in vivo after ip injections of asolanine into rabbits.

Pre-injection of mice with atropine sulfate

reduced the mortality due to 40 mg/kg a-solanine from 9/10 (controls)
to 5/10.

Pargyline and amphetamine had no prophylactic effects.

Atropine has been used as a rapid and effective means to counter the
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effects of AChE inhibition in the brain.

Intravenous injections of at-

repine restored the activity of the brain's respiratory center in 10 to
3C seconds in cats which had been given lethal doses of the centrally-

acting AChE inhibitor, tetraethylpyrophosphate (Douglas and Matthews,
1~52).

When cats were maintained on artificial respiration long enough

tc compensate for neuromuscular block of the diaphragm, they could tolerate well over the lethal dose of the organophosphate when atropinized.
Atropine is ineffective at countering the effects of AChE inhibition at
n·cotinic sites such as the neuromuscular junction.

Atropine is gener-

a·ly indicated for protection against the CNS effects of AChE inhibitors.
I: also offers some protection against AChE inhibitors which do not
reach the brain due to their inability to cross the blood-brain barrier.
Thus DuBois et al. (1952) found a tv-1ofold increase in the LD 50 of two
d'ethyl bis (dimethylamido-) pyrophosphate compounds which had been
shown to be virtually excluded from the CNS.
There is no reason to assume that the anti-AChE effects of the
sol anidine glycoalkaloids and the organophosphate AChE inhibitors
o erate by the same mechanisn1, but there are similar effects and similar
responses to prophylactic measures.

Metcalf (1971) described AChE as

hiving a "hydrophobic patch" around an anionic site, v~hich is located
aJout 0.5 nm from an esteratic site.

Nearly irreversible inactivation

r2quires the formation of a covalent bond between the serine hydroxyl
oxygen and the esteratic carbon or phosphorus atom of the interacting
m::Jlecule.

Solanidine glycoalkaloids have a tertiary amine in an

aliphatic environment, but lack ester linkages, hence covalent bonding
i

the manner of the classical AChE inhibitors appears unlikely.
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Alozie (1977) found brain acetylcholinesterase activities 79, 55,
and 19 percent of controls in male rates injected with 10, 30, and 60
mg/kg a-chaconine.

He separated rat brain homogenates into three zones

of AChE activity electrophoretically, and found one zone to be completely
inhibited at the 30 mg/kg level, one was partially inhibited at the
same dosage, and one was not affected.

In vitro studies of brain

homogenates found six ChE or AChE isoenzyme bands to be inhibited from
15.6 to 100 percent when the gels in which they were separated were incubated in 10- 4 Ma- chaconine.

No attempts were made to examine differ-

ential inhibition of AChE between different brain structures.

Differ-

ences between AChE inhibition due to a- chaconine and a-solanine were
not reported.
Alozie (1977) found a-chaconine to be a partially noncompetitive
mixed-type inhibitor of specific and nonspecific cholinesterases.

He

considered a-chaconine to be a "specific" cholinesterase inhibitor,
since it caused greater inhibition of true AChE than it did of butyrylcholinesterase.

There are numero us natural compo un ds which can non-

specifically inhibit cholinesterases.

Some of the Solanaceae deriva-

t i ves listed by Orgell (1963) were men tioned.

He also found some of

the digitalis alkaloids to be moderate inhibitors.
onins have anti-ChE activity.

Some soybean sap-

Their genins are non-alkaloidal

t ri terpenoid compounds resemb ling t he sterols in form as well as in
o t~ig in.

A soybean saponin extract vJ as found to inhibit chymotrypsin,

t r ypsin, papain, an insect larval midgut enzyme, and ram blood cell
ChE (Ishaaya and Bi rk, 1965).

Several proteins, when individually

adde d to the medium containing the saponin extract, diminished AChE
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inhibition, apparently by diluting the affected enzymes.

It is li kely

that the solanidi ne glycoalkaloids are s imilarly nonspecific.
Cardiac effects
Doses of solanidine glycoalkaloids high enough to elicit marked
CNS impairment also have marked effect on cardiac function.

A lethal

dose of a-solanine given to a rabbit caused the heart rate to increase
f~om

190 to 320 beats per minute, which rate persisted until the animal

became cyanotic (Nishie et al., 1971).

Alpha-chaconine elicited a

similar response (Nishie et al., 1975).

Although cardiac slowing is

generally the more common effect in therapeutic as well as in toxic
doses of digitalis drugs, atrial or ventricular tachycardias are observed in clinical practice (Moe and Farah, 1975).
Al pha-chaconine was abo ut 23 percent as potent as the digitalis
glycoside, K-strophanthoside, in its ability to increase the contractility of frog heart preparations by 50 percent (Nishie et al.,
1976).

In the same tests, a-solanine appeared to be less potent than

a-chaconine, but differerices were not significant.

Solanidine was 28

percent as potent as a- chaconine, and a- chaconine lacking one rhamnose
unit, B-c haconine, was only 18 percent as potent as a-chaconine on a
g/ml basis.

These tests showed that the nature of the aglycon and the

number, but not the type, of sugar moieties accounted for most of the
differences in potency between compounds.

Tomatine, another solanum

glycoalkaloid, was twice as potent as a- chaconine in increasing the
contractility of the heart.

Tests of cardiotonic drugs have shown

that the therapeutic/lethal dose ratios are similar from one drug to
the other (Farah and Maresh, 1948).

If cardiac failure were the cause
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of death due to Solanaceae glycoalkaloids and if their mechanism were
the same as the digitalis glycosides, one might expect the acute toxicity of the Solanum glycoalkaloids to reflect their cardiac potentency.
Such does not appear to be the case.
solanine and a-chaconine in

Lo 50

Tomatine was equivalent to a-

varues in the mouse, but much less

toxic in the rabbit (Nishie et al., 1975).

Although one must be

cautious in extrapolating from one animal species to another in comparing cardiac glycosides, these experiments suggest that the major toxic
effect of the solanidine glycoalkaloids probably is not a digitalislike cardiac effect.
Digitalis drugs frequently produce neurological effects in humans.
Batterman and Gutner (1948) reported visual blurring and color distortion, headache, drowsiness, restlessness, irritability, hallucinations, illusions, epileptiform convulsions, stupor, and coma as CNS
effects of digitalis toxicity.

Shear and Sacks (1978) reported delir-

ium, forgetfu l ness, neuroses, as well as other symptoms mentioned
above, and noted th at symptoms could be precipitated by any clinical
digitalis preparation.
Other acute toxic manifestations
Nishie et al. (1971) injected a rabbit with a lethal dose of asolanine, and observed delta activity in the EEG concomitant with
mar ked slovling of the respiratory rate.
but regular.
pression.

The ECG continued to be rapid

They concluded that respiration failed due to CNS de-

They speculated that CNS depression was associated with high

intracranial pressure.
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Studies by Patil et al. (1972) and by Alozie (1977) implicated an
impaired cholinergic function as the cause of respiratory failure.
Some anti-AChE compounds do not penetrate into the CNS, so that brain
AChE is not measurably inhibited and all toxic manifestations are
peripheral (Sharma et al., 1973; DuBois et al., 1952).

Other organo-

ph osphate AChE inhibitors penetrate the blood-brain barrier and cause
failure of the respiratory center (Nachmansohn and Feld, 1947; Douglas
and Matthews, 1952).

Some neuromuscular block is inevitable, and may

be the cause of death even with compounds which penetrate the brain
freely.

Douglas and Ma tthews (1952) found tetraethylpyrophosphate to

cause a rapid onset of profound neuromuscular block so that the di aphragm could not be stimulated via the phrenic nerve for 20 minutes.
The respiratory center failed, as evidenced by complete stoppage of the
phrenic nerve activity even in an artificially ventilated animal.

The

great importance of functional brain AChE activity in diisopropylfluorophos phate poison ing was illustrated by Nachmansohn and Feld (1947),
who administe red approxi mately the LD 50 to rabbits and observed at least
10 percent brain AChE activity in survivors, but invariably found near
zero activity in those which died.
The solanidine glycoalkaloids are structurally related to steroidal
hormones, and thus it is not surprising to find some overlap with hormonal function.

Satoh (1967) found that a-solanine dramatically in-

creased blood sugar levels in intact rats in doses as small as 5 mg/kg.
The effect was blocke d by adrenalectomy or by administration of various
adrenergic blocking agents or reserpine.

Neither the mechanism of

action nor the consequences of a- solanine-caused hyperglycemia were
determined, but the process appa ren tly entails the med i ation of
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epinephrine and gluconeogenesis in the liver.

Dar6czy and Hernadi

(1971) found other Solanum glycoalkaloids of the solasodine and tomatidenol groups to induce tryptophan pyrrolase activity in the livers
of rats.

The enzyme activation, an indicator of increased gluconeo-

genesis, did not occur in adrenalectomized rats.
Teratogenic effects
Much of the current interest in toxicity associated with potato
constituents stems from the hypothesis of Renwick (1972), in which he
linked blighted potatoes temporally and geographically with increased
incidence of spina bifida and anencephaly among newborns.

Solanidine

and its glycoalkaloids were suspect, and numerous tests were conducted
to prove or disprove the hypothesis.

Knox (1972) and Emanual and Sever

(1972) performed retrospective studies and found no corre1ations to
1in k potatoes with the abnorma1ities.
to be positive.

Some 1aboratory tests appeared

Mun et al. (1975 ) observed rumpless and trunk1ess chic k

emb ryos aft er injection of a-solani ne or extracts of pota toe s infected
with Phytophthora infest«as .

Sharma et al. (1978) found an anencepha1ic

fetus- in one of t wo 1 i tters of miniature swine fed Phytophthora
infestans -bli ghted potato concentrate.

They also found incompl ete

closure of the vertebral column in rabbit fetuses born to does fed
extract s of potatoe s infected
festans .

~vi

th either Alternar ia solani or P. &n-

Keeler et al. (1975) had previous1y tested four species in-

cluding the rabbit with extracts of blighted potatoes and found no
incidence of anencaphaly or spina bifida.

Systematic studies by Brown

and Keeler (1978) of various solanidan epimers suggested that the conformational requirements for teratogenicity were not met by solan -idine,
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and that the causes for positive findings of teratogenesis would have
to be sought among other compounds.
Multiple changes in brain amine levels
after administration of toxins
Only ACh has been considered thus far as a brain amine whose concentration would be expected to change in response to solanidine glyalkaloids.

There are, however, instances where other neurotransmitter

concentrations or turnover rates change concurrently with ACh.
causative chemicals are some chlorinated hydrocarbons.

Among

Hrdina et al.

(1973) found DDT to cause a decrease in ACh in the cerebral cortex
and striatum to 72 percent and 62 percent of normal, respectively.
Norepinephrine in brain stem dropped to 63 percent of normal.

Pretreat-

ment with the monoamine oxidase inhibitor, pargyline, caused a substantial increase in the 5-HT content of the brains of DDT-treated
animals as compared with controls.

Thus, serotonin was shown to have

a more rapid turnover without a change in its concentration.

Chronic

dieldrin administration to mallard ducks caused depletion of 5-HT,
NE, and DA (Sharma, 1973).
Multiple changes in biogenic amines are not routinely expected in
AC hE inhibitor studies.

The solanidine glycoalkaloids, however, are

not specific AChE inhibitors, and may well have unanticipated actions
up on the brain.

There is an ever-increasing body of evidence for a

complex intersystem communication between neurons associated with different neurotransmitters.

~:JcGeer

et al. (1977) revievJed experiments

in which cholinergic striatal interneurons stained with a marker for
choline acetyltransferase were contacted by dopaminergic nerve endings
which were traced after their degeneration caused by 6-hydroxydopamine.
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Similarly, gamma-aminoburyric acid (GABA) neurons were traced by the
3
axoplasmic flow of tritium-labeled protein or H-GABA from the pallidal
cell bodies to the substantia

nigra~

where they met degenerating dopa-

minergic neurons.
Physiological testing procedures
Toxins associated with a complex of symptoms are ideally studied
when all effects except for the one of primary interest are either he l d
constant or are under steady observation.

Numerous animal "preparations"

are used to hold constant or eliminate confounding symptoms.

Typical

of these are decerebrate animal, heart-lung, and nerve-muscle preparations.

A step further are a host of in vitro tests using isolated

organs, either intact, homogenized, or prepared otherwise, to allow
the investigator to monitor a response apart from the living animal.
Since the value of such experiments must eventually relate to the intact animal, many investigators choose to forego the convenience of
simplified preparations.

Such a choice requires monitoring of several

parameters, but animal species can occasionally be selected to minimize
confounding effects.

In the case of solanidine glycoalkaloids, if one

wishes to measure CNS effects with minimal interference of digitalislike effects, the rat is a good choice because of its relative immunity
to the cardiac effects of digitalis drugs (Okita, 1967).
EEG effects and their measurements
Nishie et al. (1971) reported an initial activation of the EEG
characterized by high frequency waves after ip administration of a
lethal dose of a-solanine.

Delta waves were observed minutes before
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death and may have reflected anoxia due to respiratory impairment.
Alpha-chaconine had a similar effect (Nishie et al., 1975).
Some anti-AChE toxins have effects similar to the solanidine glycoalkaloids.

Organophosphate AChE inhibitors have also shown an un-

stable high frequency pattern in stages in which cerebral anoxia had
not set in (Toman and Davis, 1949; Burchfiel, 1975; Rieger and Okonek,
1975).

Toman and Davis (1949) found increasing levels of such poisons

to be associated with high amplitude delta activity.

In the most severe

cases, delta activity disappeared and only low amplitude waves of relatively high frequency remained.

An irregular high frequency activity

superimposed upon slow delta waves was associated with AChE inhibition.
These symptoms could be abolished or their onset could be delayed by
atropine.
Methods for computerized analysis of random wave forms such as
EEGs have been available for some years, but only in recent years has
the cost of computer time decreased and the efficiency of wave analysis
programs increased sufficiently to make such methods practicable.
Pro bab ly the most popular and useful form of output is the power spectrum, which is described in detail in Koopmans (1974).

The "power" of

a time function is the integral of the squared value of its amplitude
over time.

A spectral representation requires that the waves be segre-

gated by frequency, so that the power values can be summed for waves
belonging to respective frequency ranges.

Segregation can be concep-

tually visualized as a matching of each wave of a record with the best
fitting sine or cosine wave.

Computers fit curves by using complex

arithmetic functions which are equivalent to these trigonometric forms.
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The power spectrum of a time series yields the power at each frequency
as a function of frequency.
Power spectra lend themselves to statistical analysis, and programs
and suggestions are abundant in recent literature for their applications
(Fails and Verlander, 1977; Rosadini et al., 1977).

Power spectra are

rather sensitive indicators of behavioral states (Coenen, 1975) .

Be-

havioral or awareness states must be stabilized as much as possible in
order to perform meaningful pharmacological tests (Gramsbergen, 1976).
Recordings of the visual cortex of the alert rat have a peak in the 6
Hertz (Hz) range (Gramsbergen, 1976), which becomes less predominant
and may be obliterated after administration of compounds with pronounced excitatory or depressant effects.
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MATERIALS AND METHODS
Animals
Adult male Sprague-Dawley deriv€d rats (Simonson Laboratories,
Gilroy, California) averaging 283 g body weight were used in all tests.
All were acclimatized to the surroundings for 7 to 10 days before testing.

They were fed a commercial laboratory chow and had free access to

feed and water except during experiments.
Preparation of a-chaconine
The test compound, a-chaconine, was prepared from freeze dried
potato sprouts.

These were extracted into acetic acid and the glyco-

alkaloids were precipitated with ammonium hydroxide (Gull and Isenberg,
1960).

Silica Gel G (Applied Science Laboratories, State College,

Pennsylvania) was used to separate the compounds by thin laye r chromatography using the solvent system 1-butano l :acetic acid:water (10:3:1)
(Zitnak, 1968) .

Alpha-chaconine was identified as the second band from

the origin (Zitnak, 1968 ).
standard of a-chaconine.
commercial a-solanine.

It had an Rf identical to a commercial
The only other prominent band corresponded to

Alpha-chaconine was dissolved in dimethyl

sulfoxide-propylene glycol (3:7) (Nishie et al., 1971), and concentrations were adjusted to make injection volumes of approximately 0.5 ml.
Electroohysiological tests and other
observations of live animals
Instrumentation for e1ectrophysiological experiments.
ECG, respiration, and blood pressure readings were made on a

All EEG,
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Physiograph-Six recording unit (Narco Biosystems, Inc., Houston, Texas).
The EEGs were additionally recorded on an analog/digital computer (EAI
590 System, Electronics Associates, Inc., West Longbranch, New Jersey),
after signal amplification on the Physiograph unit.

The amplifiers

and transducers with their accessories were Narco products.

Channel

Emplifiers, Type 7070, processed signals from a variety of couplers.
Hi-Gain Couplers, Type 7171 received EEG and ECG signals.

Respiration

measurements utilized an Impedance Pneumograph Coupler, Type 7212.

An

Electrosphygmograph Coupler, Type 7211, measured blood pressure with the
aid of a Pneumatic Pulse Transducer and a 7/16 inch metal tubular tail
cuff.

Instrumental settings and testing procedures were made according

to general suggestions of the Narco Physiograph manual, and amplifications were adjusted to produce convenient
chart recorder.

tr~ce

amplitudes on the strip

A small heat lamp was used to warm animals before

takin g blood pressure measureme nts with the tail cuff.

Shielded cables

were employed to reduce electrical noise in the EEG records.
As the EEG records were being recorded on the strip chart recorder
of the Physiograph unit, the preamplified signals were carried from
the Physiograph to the analog/digital computer.

When actuated, the

computer recorded voltages of two channels simultaneously.

Voltage

differences were recorded in digital form at intervals of 0.0171 seconds
for 600 counts (10.26 seconds elapsed time).

When recordings were com-

plete, the digital tape was sent to the Burroughs Corporation in Salt
Lake City to be transcribed into a format compatible with a Burroughs
6700 digital computer, which performed the EEG data reduction.

Power

spectra were performed by the IMSL subroutine "FT FREQ" (International
~·1athematical

and Statistical Library, Houston, Texas).

Plots and
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associated data manipulations utilized the computing system ''Minitab
II" (Professor Thomas A. Ryan, Jr., The Pennsylvania State University,
University Park, Pennsylvania).
Animal preparation prior to electrophysiological tests.
stainless steel machine

scre~<;s

Small

1.6 mm in diameter served as leads to

regions of the cerebral cortex, and also formed the leads for reference
electrodes and for electrical grounding of the animals (Schiff, 1974).
Screws had previously been soldered to 5-cm lengths of insulated speaker
cable, which were stripped of insulation at both ends for making connections.

Wires containing a large single strand of metal were more

satisfactory than multifilament types.
Surgery and 1ead arrangements fo 11 01~ed the method of Gohd et a 1.
(1974) except for the placement of reference electrodes and ground leads.
When a rat was sufficiently anesthetized under 40 mg/kg of pentobarbital, i t was mounted on a stereotaxic instrument.

The skull was bared

and dried, and holes were made with a dental drill fitted with a bit of
proper size to allow the electrodes to be screwed tightly until the
tips rested on the dura mater.

Frontal, parietal, and occipital leads

were placed in a line 3 mm lateral to the saggital suture.

Frontal

and parietal electrodes were placed 3 mm rostral and 3 mm caudal to the
coronal suture, respectively.
the lambdoid suture.

The occipital lead was 1 mm rostral to

The left side of the brain was arbitrarily chosen

for the primary electrodes.

The parietal location on the right side

served to ground the animal for EEG, ECG, and respiratory measurements,
and to help anchor the headgear.

A reference electrode was located 3

mm caudal to the intersection of the saggital and lamdoid sutures (D. E.
Shearer and E. Snyder, personal communication).

A diagrammatic
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representation of the lead configuration is given in Figure 2.

A gen-

erous application of dental cement anchored the leads in place and insulated the extracranial portion of the leads.
sutured with surgical gut.

The incision was then

Lead wires were wrapped with strapping tape

to protect the headgear and to prevent the rats from becoming snagged
in the wire cage tops.
surgery.

All rats received 0.1 ml of Combiotic® after

A minimum of 10 days passed before testing began .

On the day of testing, rats were temporarily anesthetized with
ethyl ether.

A pair of sterling silver wire electrodes was implanted

for EEG and respiratory measurements.

Placement was in the right side

of the chest and on the left portion of the groin, essentially the
"Position II" of classical electrocardiography.

\~ires

were conveniently

placed by first inserting a large-gauge nee?le under about l em of skin
and allowing the tip to protrude, then inserting the wire into the
needle before withd rawing the needle.
prevented short circuits.

Tape wrapped around the wires

Rats were restrained by tying all limbs with

strapping tape, and placing animals into cylinders made of copper screen.
Thus secured, they had some whole-body flexibility and yet were sufficiently immobilized to maintain a favorable ECG axis and to permit
tail cuff blood pressure recording s .

A rat prepared for testing is

shown in Figure 3.
Electrophysiological testing procedures.

Measurements of EEG,

ECG, and respiration in response to sublethal doses of a -chaconine were
recorded in a single session.

Technical difficulties prevented con-

current recordings of blood pressures, therefore records of preliminary
tests were used for blood pressure data.

An additional rat was given a

lethal dose of a-chaconine (40 mg/kg) and EEG, ECG, blood pressure, and
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Right

Left

Saggital
suture

Front a
Coronal
suture

Parietal

Parieta l

Lambd oid
sutur e

Occipital

Ref erence

Figure 2.

Illustration depicting locations of electrodes for EEG
studies. (Left frontal, parietal, and occipital leads used
cerebellar reference electrode. Right parietal lead for
grounding of animal. Magnif ication 3X.)
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A

B

Figure 3.

Rat implanted with electrodes for physiological testing.
A.
B.

Showing tail cuff, ECG leads emerging from restraining
cage, and alligator clips for electro physi ological
recordings.
Close-up of headgear. The five leads correspond to the
five positions shown in Figure 2.
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respiration data were monitored on the Physiograph until the death of
the animal.
The main experimental session involved 12 rats, 3 per dosage level
and 0, 10, 20, and 30 mg/kg a-chaconine.

Immediately before injection,

each rat was monitored to give a baseline record to serve as its own
control.

In addition to samples of ECG and respiration activity, two

10.26-second EEG periods were recorded digitally for each of the three
cortical locations, using the cerebellar lead as an indifferent electrode.

The first and second post-injection recordings followed 3 and

7 hours later.
Analysis of power spectra.

Power spectra for EEG analysis were

calculated in steps of l. 01 Hz, thus the "6 Hz" band refers to the pmver
in the frequency range 6.05

±

0.50 Hz.

Records vitiated in part by

muscle movement were "edited" by removing from consideration whole
10.26-second recordings of affected leads, the more objectionable halves
(5.13 second) of records, or a combination of the two.

In all cases, a

minimum of one 5.13-second recording was used for each lead on each
rat at each time interval, and the contributions from each animal to
group-averaged power spectra were weighed equally.
Power spectra were summed for rats treated alike and were subjected
to statistical comparisons.

Because of large differences in the ampli-

tudes of EEG signals between animals, and because the total power varied
in a non-Gaussian fashion (see Appendix A), the nonparametric Wilcoxon
rank-sum test (Lapin, 1975) was used to compare dose-related differences
in total power in the range 3-29 Hz.
For studies of shifts of predominant frequencies, the raw power
spectra were first "normalized" in the range from 3 to 29Hz by dividing
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the pov1er of each frequency band by the total pov1er in that range.

An

apparent shift of the 6 Hz peak to lower frequencies was investigated
by examining the changes in the ratios of power at 6 Hz over power at
5 Hz in response to a-chaconine.

A two-tailed t test was used for

analysis (Lapin, 1975).
Manifestations of toxicity by visual inspection.

Rats treated with

a-chaconine for the neurotransmitter determinations as described in the
next section were observed visually for signs of sedation, sluggishness, constriction of abdominal muscles, or breathing impairment.
ings were

reporte~

Find-

in a tabular form.

Neurotransmitter determinations
Forty-eight rats were divided into four dosage level groups, and
each level was further divided into two groups based upon the time
interval between dosing and sacrifice.

Extracts of each brain sample

were sp lit into fractions for all neurotrans mitter dete rm inations.
Neu rotran smitter concentrations were calculated in terms of nanomoles
per gram fresh weight of brain.

Differences between controls and a-

chaconine-dosed rats were analyzed by a two-tailed t test with a 95%
confidenc e interval.
Chemi cals and chemical assay equipmen t.

All biogenic amine

standards were purchased from Sigma Chemical Company (St. Louis,
Missouri).

They were formulated as the following salts:

acetylcholine

iodide, norepinephrine HCl, dopamine HCl, serotonin creat i nine sulfate,
and 5-hydroxyindole-3-acetic acid dicyclohexylammonium salt. Adenosine
5'-triphosphate, tetra (triethylammonium) salt (y - 32 P) ~1/as purchased
from New England Nuclear (Boston, f'1 assachusetts).

Yeast choline kinase
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and AChE (from Electrophorus electricus ) were purchased from Worthington
Biochemical Corporation (Freehold, New Jersey).
analytical grade reagents and solvents.

Other chemicals were

The latter were redistilled

and acid washed when used for fluorometric analyses.

Distilled, de-

ionized water was employed for all chemical tests.
Fluorometric determinations were made on an Aminco-Bowman Spectrophotofluorometer (American Instrument Company, Inc., Silver Spring,
~1aryland).

Radioactivity measurements in the method for acetylcholine

were made using a Packard Tri-Carb Liquid Scintillation Spectrophotometer (Packard Instrument Company, Inc., Downers Grove, Illinois).
(Details will be discussed later in the paper.)
Animal sacrifice and brain tissue extraction.

Animals were

accommodated to a regular daylength schedule and familiarized with a
rat dipping cage in advance of the time of sacrifice (Smith et al.,
1975).

A 12-hour light period beginning at 6:00A. M. was established

2 weeks before testing.

Rats were exposed to a sham dipping apparatus

fou r times during t he week before sacrifice, and daily during the week
in which the rats were killed.

Each rat was made to run throu gh the

cylindrical chicken wire cag e during the accommodation sessions.
Twelve rats, three at each of four dosages, were sacrificed on
each of four consecutive mornings.

In each case the rats were trans-

ported on the evening before sacrifice to a fa cility convenient to a
la rge refrigerated room for processing of tissues.

Rats to be killed

3 hours after dosing were injected between 6:00 and 7:00 A.M.

Those to

be killed after 12 hours were injected between 9:00 and 10:00 P. M. of
t he evening befo re .

Doses of a -chaconine were 0, 3, 8, and 20 mg / kg.

Rats were caged individually after injection.
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Rats were killed by dipping for 10 seconds in liquid nitrogen
according to the "near freezing" method of Takahashi and Aprison (1964).
Brains were removed after saggital section of the head, and were immediately frozen in liquid nitrogen.

Extraction and cleanup followed

the method of Smith et al. (1975) . .frozen brains v1ere ground in liquid
nitrogen in a porcelain mortar.
and extracted into 1

~formic

About 1 gram of the powder was weighed

acid/acetone (v/v:l5/85).

Four additional

tubes of pooled brain matter were extracted and fortified with 0, 2,
or 4 nanomoles of NE, DA, 5-HT, and 5-HIAA.
parallel with the rest of the samples.
volumes of heptane/chloroform (8:1).

These were handled in

Extracts were washed with two
The aqueous phase was adjusted to

5 ml by distilled water addition or by blowing with nitrogen gas.
sample was split into three fractions.

Each

A 2-ml portion was transferred

to a vial for analysis of NE, DA, and 5-HT.

Another 2-ml portion was

measured for ACh, and a 0.5-ml fraction was prepared for 5-HIAA determination.

All vials were frozen and then freeze dried.

They were

then ca pped and stored at -30 °C.
Acetylcholine assay.

The method of Goldberg and rtJcCaman (1973)

was used for ACh determination.
in ltJater of pH 6.6.

Lyophilized samples were reconstituted

Quate rn ary amines vJere extracted into a solution

of tetraphenylboron in 3-heptanone.
acidic solution and lyophilized.

The amines were re-extracted into

Samples were reconstituted with a

buffer solution containing ATP, MgC1 2 , and choline kinase. After a
brief incubation to phosphorylate choline and interfering compounds, an
aliquot of ATP (Y - 32 P) and AChE was added to hydrolyze the ACh and
to permit a portion of the label to appear in the newly phosphorylated
choline.

Removal of unused labeled ATP was accomplished by precipitation
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with barium acetate and by passage of an aliquot through an anion exchange resin.

Samples were washed directly into a scintillation cock-

tail and counted.

Quantiative estimates were based on simultaneously

run standard samples.
Assays of norepinephrine, dopamine, and serotonin.

Norepinephrine,

DA, and 5-HT were determined by the method of KarasavJa et al. (1975).
Samples were reconstituted in a buffer of pH 8, and layered onto small
columns of alumina, which were superimposed over similar columns of a
weak cation exchange resin.

Columns were washed with water, first in

tandem and then separately.

Alumina columns were eluted with 0.2 M

HCl for determinations of NE and DA.
with 0.5 M HCl for 5-HT estimation .
the Karasawa procedure:

The resin columns were eluted
One notable exception was made to

the "heated tissue blank" suggested by Smith

et al. (1975) was used in 5-HT estimations in favor of the tissue blank
method of Karasawa et al. (1975), since the latter gave excessively
hig h blan k values.
Determination of 5-hydroxyindoleacetic acid.
and Sayre (1971) was employed for 5-HIAA assays.

The method of Anton
The cleanup entailed

an initial precipitation of protein contaminants with perchloric acid.
The supernatant was made acidic and washed with chloroform, then extracted into ethyl ether, and finally re-extracted into water adjusted
An aliquot was made strongly basic with K3Po 4 and heated to
form the fluorophore.

t o pH 8.
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RESULTS
Live animal experiments
Effects of a lethal -dose.

A rat injected ip with 40 mg/kg a-

chaconine displayed a steady increase in heart rate until death (Figure
4).

Respiratory rate was steady for the first half hour, then began to

increase markedly.

Breathing became much slower and more labored

during the last few minutes of life.

Blood pressure could not be

measured after one-half hour following injection because of reduced
peripheral blood flow, but appeared to be rising slightly during the
first 30 minutes.
Effects of sublethal doses on heart and respiratory functions.
Rats given a-chaconi.ne doses of 20 to 30 mg/kg ip underwent marked
bradycardia (Figure 5).

Ten mg/kg doses caused significant tachycardia.

Blood pressure records of eight rats injected with 0 to 30 mg/kg showed
no consistent pattern (Figure 6).

Transient high blood pressure was

observed in two rats given 20 and 30 mg/kg, respectively.

These peak

pressures were neither sustained by the affected rats, nor were they
observed generally at any dose level.
Respiratory rates did not vary significantly with sublethal doses
(Figure 7).

A trend seemed to be toward a lower rate 3 hours after in-

jection and toward a higher rate 7 hours after dosing with higher amounts
of a-chaconine.
Effects of sublethal doses on EEG .

The parietal and occipital EEG

patterns showed increased slow wave activity at doses of 20 to 30 mg/kg
(Figure 8).

Frontal EEGs were not noticeably affected by the toxin.
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Effects of intraperi toneal injec t ion of 40 mg/kg a-chaconine
on heart rate, respiratory rate, and blood pressure of a rat.
(P indicates preinjection measurement.)
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Effects of sublethal doses of a-chaconine on blood pressure
in rats. (One to three rats per dose level, each indicated
by a different line.)
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Occipital lead before injection.
Parietal lead 3 hours after injection.
Occipital lead 3 hours after injection.
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There was no difference in total power of any brain region (data shown
in Appendix A).

The averaged occipital power spectra for rats treated

with 30 mg/kg show features which were observed in most cases (Figure 9).
The reduction in overall power which was observed 7 hours after injection in this figure was general for

~ontrols

and was not related to a-chaconine levels.

and for all dosage levels,
The disappearance of the 6

Hz peak after injection was common.
The relative predominance of the 6 Hz peak was measured by taking
the ratios of the power at 6 Hz over the power at 5 Hz.

This was done

for individual rats in all cortical locations at each time interval.
Table l scores the number of rats in which the 6 Hz/5 Hz ratio exceeded
unity in each category out of three rats per dose level.
records showed no pattern.

Frontal

Parietal records showed essentially uni-

form disappearance of the 6 Hz peak at all dose levels.

The occipital

record showed a marked response to a-c haconine with a dose-related disappearance of the 6 Hz peak.

When the ratios were averaged and sub-

jected to analysis of vari ance (Lapin, 1975), significant reduction in
the 6 Hz/5 Hz power ratio appeared at the 10 mg/kg level (Table 2).
Clinical effects of a-chaconine.

Results of visual observations of

rats treated with sublethal doses are summarize d in Table 3.

One case

of respiratory impairment was associated with a 3 mg/kg dose.
ized symptoms were first seen at the 8 mg/kg level.

General-

Sedation, sluggish-

ness, constriction of abdominal muscles, and impaired breathing were
typical at the 20 mg/kg level.

These symptoms were transitory.

of the 20 mg/kg rats showed symptoms after 4 hours:

Only 3

these displayed

marked constriction of the abdominal muscles or mild sedation in the
fifth hour after dosing.
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Table l.

Changes in EEG power spectra after a-chaconine administration:
number of rats in which power at 6 Hertz exceeded power at 5
Hertz at different dosages as a function of timea
Frontal

Dose
(mg/kg)

p5

3

7

Parietal
Hours after injection
p
3
7

0

0

0

0

0

0

0

10
20

0

0

30

0

0

3

3

Occi Qita l
p

3

7
2

0

0

3

2

0

0

0

2

0

0

0

0

3

0

0

~Three rats per dosage group.
P = preinjection. Record taken immediately prior to injection.

Table 2.

Effect of a-chaconine on power spectra of EEGs of the occipital
cortex of ratsa

Dose
(mg/kg)

Preinjection

Hours after injection
3

0

0.985 ± 0.069

0.998

± 0.115

l. 070

10

l. 321 ± 0.090

0.894

± 0. 141

0.878* ± 0.028

20

l. 156 ± 0.116

0.399* ± 0.041

0. 572* ± 0.100

30

l. 190 ± 0.072

0.607* ± 0. 133

0.629*

7
± 0.125

±

0.069

aThe ratio of power at 6 Hertz over power at 5 Hertz is given as the
average for rats treated alike± S.E.M., n = 3.
*Indicates values significantly different from preinjection levels
(p < 0.025).
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Table 3.

Visually observed signs of toxicity of a-chaconine in ratsa
S m toms
Abdominal muscle
Sluggishness
constriction

Dose
(mg/kg)

Sedation

0

0

0

0

3

0

0

0

8

6

0

4

4

20

7

10

10

6

Impaired
breathing
0

aTwelve rats per intraperitoneal dose level.

Neurotransmitter Assays
The influence of a-chacon ine on whole rat brain ACh is presented in
Table 4.

No changes were associated with the toxin.

An unexpected

difference between the ACh levels in rats associated with the two preinjec ti on intervals was significant according to the t test (p

<

0.025).

No systematic changes associated with dosage were observed in either
preinjectio n group .

Table 4.

Acetylcho l ine contents of rat brain following intraperitoneal
admi nistration of a-chac onine
Hours after treatment a

Dose
(mg/kg)

12

3

0

16. l

±

3.4

31.2

±

5.8

3

20.0

±

5.3

32.3

±

8.0

8

25.2

±

6.4

29.7

±

7.0

20

16.3

±

3.2

24.4

±

3. l

aThe average concentration in nanomoles/gram

± S.E. ~·1.

(n

=

6).
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The catecholamine levels did not vary significantly after doses
of up to 20 mg/kg (Table 5); however, NE showed a downward trend in the
3-hour group.

Serotonin and 5-HIAA were unaffected by a-chaconine

treatment (Table 6).

Table 5.

Catecholamine contents of rat brain following intraperitoneal
administration of a-chaconine

Brain
catecholamine

a
Hours after treatment
12
3

Dose
(mg/kg)
0

2.56

±

0.10

2.95

±

0.24

3

2. 71

±

0.15

2.45

±

0.08

8

2.46

±

0.10

2.97 ± 0. 19

20

2.27

±

0.17

2.57

±

0. 19

0

4.13

±

0.31

4.48

±

0.45

3

5.25

±

0.30

4.38

±

0.59

8

4.94

±

0.38

6.75

±

l. 10

20

4.67

±

0.82

5.07

±

l. 01

Norepinephrine

Dopamine

aThe average concentration in nanomo1es/gram

±

S. E.M. (n

=

6).
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Table 6.

Serotonin and 5-hydroxy indoleacetic acid contents of rat
brain following intraperitoneal administration of achaconine

Brain
amine

0

2.00

±

0.16

1.78

3

2.09

±

0. 17

l. 92 ± 0.22

8

2. 16

±

0.04

l. 87 ± 0.34

Serotonin

±

0.17

l. 94 ± 0.09

2.12

0

1.68

±

0.54

l. 80 ± 0.83

3

2.30

±

0.93

l. 63 ± 0.51

8

1. 82 ± 0.29

2. 01

20

l. 67 ± 0.49

l. 88 ± 0.82

20

5-Hydroxyindoleacetic acid

Hours after treatmenta
12
3

Dose
(mg/kg)

aThe average concentration in nanomoles/gram

±

S.E.M. (n = 6).

±

±

0.13

0.79
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DISCUSS I Of~

Visually and electrophysiologically
ob served effects
A lethal dose of a-chaconine elicited symptoms in rats similar to
those reported for a-solanine (Nishie et al., 1971) and for a-chaconine
(Nishie et al., 1975) in rabbits.

Heart rate and respiratory rate

increased i ni ti ally, after which the respiratory rate fe 11 concurrently
with the appearance of slow wave EEG activity.

The heart continued to

function after EEG and respiratory activity had ceased.
Signs of a-chaconine poisoning were apparent with doses as low as
8 to 10 mg/kg.

They included a shift of the predominant EEG fre que ncies

toward slow wave activity, especially apparent in the occipital cortex.
The slow wave predominance associated with a-chaconine was apparent
even at low doses, in contrast to typical effects of lov1 levels of
organophosphate AChE inhibitors, which cause an increase in high fre qu en~y

activity (Hyde et al., 1978; Rieger and Okonek, 1975).

Abdomina l

muscle constriction, tachycardia, impaired breathing and sedation were
observed at the same level.

Higher doses caused marked sluggishness.

Of these symptoms, only abnormal EEGs and tachycardia persisted for more
t han 4 to 5 hours.
The heart was measurably slowed at doses of 20 to 30 mg/kg,
sugg estive of digitalis drugs at therapeutic levels (Rosen et al., 1975).
This was a stark contrast to the effect of a lethal dose, 40 mg/kg,
whi ch increased the heart rate to 60 percent above normal.

Blood

pressure changes showed no consistent pattern at a- chaconine levels up
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to 30 mg/kg.

The lack of adverse cardiac effects at doses higher than

sufficient to cause central and peripheral effects is evidence that
CNS depression was not associated with heart effects.

Slow wave

activity appeared in the EEG at dose levels to small to be associated
with anoxia.

It is apparent that CNS depression is a primary effect of

a-chaconine.
Neurotransmitter effects
Acetylcholine levels for rats sacrificed 3 hours after dosing were
within the range reported for rats sacrificed by the near-freezing technique (Smith et al., 1975).

Rats dosed 12 hours before sacrifice had

ACh levels about 30 percent higher than reported for this sacrifice
method.

It is possible that the comparatively low ACh values of the

3-hour group compared to the 12-hour group was because the effects of
the excitement of being hand led and injected had not worn off before
sacrifice.

Tissues from the two groups were processed separately, so

that differences may have resulted from batch -to-batch variat ion .

There

was no systematic dosage response within either group.
Brain concentration of a-c haconine has been shown to be near maximal during the period between 3 and 12 hours after dosing (Alozie,
1977).

Since he showed that AChE was measurably inhibited in the range

of 20 mg/kg a-chaconine, it would not have been surprising to have found
a response reflected in ACh levels.

This was not observed.

It is

possible that brain ACh levels had undergone a rapid rise and fall
before 3 hours had elapsed.

Studies by Trabucchi et al. (1975) showed

marked reduction in ACh turnover after injection of physostigmine or
the anti-muscarinic drug, oxytremorine, both of which cause initial
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increases in brain ACh content.

Such feedback inhibition could account

for a return to normal ACh content in rat brain observed 24 hours after
injection of the potent AChE inhibitor, diisopropylfluorophosphate (DFP),
at which time brain AChE was still 91 percent inhibited (KevJitz et al.,
1977).

The turnover time of ACh varies from about 0.9 to 5.6 minutes

in different brain parts (Stavinoha et al., 1976).

It is not surprising

that these and other investigators found brain ACh levels to reach a
plateau within a few minutes after the administration of anti-AChE
drugs:

sufficient ACh to signal a need for a production slowdown was

available within minutes.

In view of the rapid turnover time of ACh

and of the capacity of the brain to return to normal ACh levels even
when over 90 percent of AChE is inhibited, it is not surprising that no
alteration in ACh was observed 3 hours after injection.

Whether or not

the more transient symptoms associated with a-chaconine administration
resulted from a brief increase in ACh can be resolved by measuring
ACh levels at shorter inte r vals.

The persistent CNS effects such as

slow wave EEG pat t erns were found not to relate to alterations in ACh
levels of whole brain.
It has been sugge sted that ACh content might not always change
significantly in whole brain in response to a drug or toxin even when
sufficient alteration of ACh might occur in key brain parts to have a
pharmacological effect (Watanabe and Sharma, 1972; Modak et al., 1975).
Sensitive radiochemical methods such as that of Goldberg and

t~cCaman

(1973) offer sufficient sensitivity to allow measurement of the ACh
content of specific brain parts.

A recent method for separating ACh

into "free," "labile bound," and "stable bound" fractions has been reported (Kewitz et al., 1977), which could be used to detect changes in
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ACh content within the cell in response to a-chaconine.

Such a study

could distingu i sh changes in the ACh pools considered to be more biologically significant (bound forms) fro m the "free" pool.

It

would also be

useful to follow change s i n the subcellular distribution of a-chaconine
over time (0.5 to 12 hours) and the rates of recovery of AChE isoenzymes
in the brain over time.

Alozie (1977 ) reported both items in rats

sacrificed 3 hours after dosing.
The apparent failure of other neurotransmitter levels to respond to
a -chaconine injections suggests that persistent CNS changes were not associated with alterations in NE, DA or 5-HT content.

The lack of change

in 5-HIAA levels is evidence that 5-HT turnover was not greatly affected.
A slight decrease in NE levels in the 20 mg/kg group, although not stat i stically significant, implied t hat alterations in levels of this biogenic
amine may have been associated with a-chaconine toxicity at high dosages.
It is necessary to determine the relative importance of the central
and peripheral effects of a-chaconine.

It is possible to show pharma-

cological effects on the CNS when mortality results from a peripheral
failure, typically neuromuscular block at the diaphragm.

Subsequent

investigations might well begin with physiological preparations designed to distinguish betvJeen the modes of toxicity.

A good model for

such experimentation is the test series of Douglas and Matthews (1952).
They monitored the impulses of the phrenic nerve to follow the activity
of the respiratory center.

In other experiments they stimulated the

same nerve to test the responsiveness of the diaphragm to nerve impulses.
The vagus nerve activity could also be monitored in view of a-chaconine
effects upon the heart.

These investigations should precede any exten-

sive continuance of studies of a-chaconine effects upon the brain.
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SUMMARY AND CONCLUSIONS
Central nervous system effects of a-chaconine were investigated
electrophysiologically and by determination of brain biogenic amines in
response to acute ip injections of the glycoalkaloid.

Visually ob-

servable manifestations of sedation and respiratory difficulties were
noted.
A lethal dose of 40 mg/kg a-chaconine caused profound tachycardia,
which persisted until the death of the animal.

Respiration rate

accelerated to a point, then fell simultaneously with the appearance
of high-amplitude delta activity in the EEG, signaling anoxia.

It was

not clear whether peripheral respiratory failure, failure of the brain
respiratory center, or heart effects were responsible for the death of
the animal.
Sublethal doses caused marked but generally short-lived symptoms
in rats.

Eight mg/kg a-chaconi ne caused sedation, constriction of

abdominal muscles, and respiratory difficulty.

These symptoms were

more pronounced and were accompanied by general motor sluggishness at
the 20 mg/kg level.

These effects did not persist for more than 4

hours except for a few of the rats administered 20 mg/kg.
Electrophysiological tests found cardiac and brain function to be
significantly altered by sublethal doses of a-chaconine.
tion was affected at doses as low as 10 mg/kg.

Heart func-

Twenty to 30 mg/kg

slowed the heart rate significantly, while 10 mg/kg caused tachycardia.
Cardiac alterations at these dosages did not appear to be pathological.
Respiration rate and blood pressure did not vary significantly in
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response to a-chaconine.
low as 10 mg/kg.

The EEG changed significantly at doses as

The major effect on EEG was a disappearance of the

prominent 6-Hertz peak and a predominance of slow wave activity.

The

EEG and cardiac effects persisted lon ger than other observed physiological effects.
The effects of a-chaconine on brain biogenic amine levels were
studied.

Doses up to 20 mg/kg failed to significantly change levels

of ACh, NE, DA, 5-HT, or of the serotonin metabolite 5-HIAA in animals
sacrificed 3 or 12 hours after injection.

The lack of alterations in

ACh levels suggested that CNS effects were not associated with changes
in brain ACh content.

It was suggested that subsequent experimentation

should involve physiological preparations capable of determining the
major site of toxicity of a-chaconin e.

Whereas e1ectrophysiological

tests suggested that the CNS v1as the primary target of a-chaconi ne
toxicity , brain amine assays offered few clues about the mechanisms of
toxi.c effects.
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Appendix A
Power Spectra of Rats at Three Cortical Locations
Table 7.

Dose
(mg/ kg)
0

10

20

30

Total power in power spectra of rats in the frequency range
3 to 29 Hertz at three cortical locationsa
Frontal

Parietal
Hours after injection
p
3
7

Occipita 1
p

3

7C

224

213

150

22

608

867

271

91

30

1 '178

870

1 '066

205

180

40

371

608

612

559

206

211

22

604

788

1'034

926

830

196

72

12

143

195

252

311

285

732

102

38

6

416

399

409

661

415

516

203

84

18

141

222

223

727

127

357

240

54

57

1. 602

236

373

360

307

564

133

49

2

631

88

467

791

968

581

187

254

71

485

247

303

245

184

219

74

24

33

469

454

297

369

906

488

243

144

13

p5

3

7

715

1, 499

425

171

508

423

554

72,979

714

374

424

386

195

1,61 8 1 • 735

aVa1ues associated with three dosage s of a -c haconine and controls are
compared as a function of time. Spectral power of individual animals;
bthree rats per group.
P = preinjection me asurement.
cOcc ipital values were consistently low in ~ats after 7 hours; not doserelated.
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Appendix B
Program Used by Analog/Digital Computer to Digitize Voltage Recordings 1
P~O GRAH

C

TO DIGITIZE THROUGH 3 A·D CHANNELS
SCALEQ FRACTION A(J)
DIMENSION ICOA(15Cl 1 ICOB(15 ~ l
DEFINE IC DA ( 1 3 ~~0~ ) 1 IC DB( 1 Jl 0~0 )
CALL ll!O HY]N CIE~R I 58(':)
CALL QSC (1,IF.RR)
C
~ELECT TAPE DRIVE 1 15
CALL QMDN(?.2 1 1 1~)
TYI-'E 250
25~ FO~HAT(R0H E~TER SE NSE CHANNEL AND FIRST INPUT CHANNEL'/ )
ACCEPT 251,ISEN,IN
251 FOKHAT(2I5)
17 TYPE 830
830 FDHMAT(60H LOAD TAPE 1 / )
C
WRITE END OF FILE AT BEGINNING OF TAPE
OCT 2~ec.H,
CALL QHON(15)
IFILE=~

1 ~ TYPE 260
26~ FOHHAT(60H ENTER RUN NO , AND NO, OF SAMPLES TO DIGITIZE'/)
C
IF RUN NO : 0 CLOSE TAPE AND RE~INO

ACCEPT 2 0 1 1 IRU NA ,ISA MPL
IFCIRUNA, GT ,99 99 ) GOTO 10
IF (I RUNA ,E 0,0 l GO TO 5e1
NREC=ISAr~PL/5~

2~5

TYPE 2>15

FOHHAT(1~HENTER

2 OCT

C

DATA /)

250I:H~

IFILE=IFI LE+1
IRt:C= <l
SET UP RECORD PACKET 0 AND 1 FDR WRI TI NG OUT ON TAPE

1

15

LA
/ 1 2 ~Hl Hl
OCT 16r760

LA 1'3"225
OCT 16V51
LA / 1 ~ 000;)
OCT 16r'762
LA / 1 2VJCll(l
OCT 160754
LA 1'31225
OCT 16<1765
LA / 31 0~0
OCT 16Vl766
C
START THE SA~ 0 LING LOOP
C
LOAD BUFFER ICUA
C
SET ~I: 1
21'l3 OCT 20 \Hhl
STA N
C
SET INDEX REGISTER TO ZERO
OCT 2574(;1
DC r 26520
1

c

C
C

c

READ SENSE LINE ~ AND TEST FOR HIGH
UNTIL HIGH IS :5EilSED
2B1 OCT

1

IF HIGH SAMPLE, IF LOW LOOP

2~42

AND !S EN
OCT 27A07
J

C

• 201

STORE INDEX REGISTER AS IR
OCT 265~Hl
STA IR

1credit for program belongs to Dr . A. Leon Huber, UWRL 123C, UMC
82, Utah State University. Computer type: EAI 590 System, Electroni cs
Associates, Inc., West Longbranc h, New Jersey.
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c

C

SAMPLE uATA AND A•D CONVE RT

c

CALL

QR5~DS(A,IN,3,IEPR)

~E~TORE

I NDEX RtGISTfR
LA IR
OCT 2651'1~
LA A
STA ICDAr1
LA A+1
STA ICDAt1r1
LA t.+2
STA ICOA+2,1
INCREMENT INDEX REGISTER BY 3
OCT 22 0[1 3
ADD ONE TO N AND CHECK FOR FULL BUFFER ' IF FULL ~RITE IT OUT AND
START FILLING BUFFER ICDB

C

C
C
C

~7

N

LA /51
11 N
OCT ?.741~
J

c

C
C

• 2~ 1

BUFFER ICDA IS FULL
CHECK STATUS OF DMAC ••• ERROR MESSAGE IF liOT READY

c

OCT 4037
OCT 2<~10il
J

• 150

TYPE 280riREC
280 FOH~AT(6~H DATA TOO FAST FOR TAPE TRANSFER RATE'/
5I5,60H RECORDCS) WERE SUCCESSFULLY TRA N SFE~RED TO TAPE'/)
PAUSE
17~

J

c

• 4~ 1

WR!TE ON TAPE

C

c

1

1~

SELECT TAPE UNI T

C

150 LA

BUFFER ICDA
1

15

/ 1 3 MJ01

OCT 54\.l
OCT 1414
I NCRE MENT IPEC BY 1
07
IREC
LA NREC
11 IREC
OCT 2741)7

C

J

C

A~D

TEST TO SEE IF DUNE

, A 01

LOAD BU FFE R ICDB
OCT 2t'I<H10
STA N

C

SET INDEX REGISTER TO ZERO
OCT 2674 0
OCT 26500
3~1

OCT 2042
AND !SEN
OCT 27407
J

C

c

C

c

• 30 1

OCT 21i5 00
STORE INDEX REGISTER AS IR .
STA !R
SA MPLE DATA ANU A•D CONVERT

60

CALL

c

C

QP5ADS(A,IN

1 ~ 1 IERR)

RESTORE INr.EX REGISTER
LA IR
OCT 25500
LA A
STA ICDB t1
LA A+!
STA ICDB+! 1 1
LA A+2
STA ICDEi+?. 1 1
I NCR EMENT INDEX REGISTER B V 3
OCT 220~3
ADD ONE TO N ANO CHEC K FOR FULL BUFFE R
STA RT FILLING ~UFFER IC DA

C
C
C

07

N

LA

/51

I

IF FULL WRITE IT OUT AND

N
OCT 27410
11

J

c

,3 0 1

BUFFER ICDB IS FULL
CHE CK STATUS QF DMAC

C
C

c

'I I

ERROR MESSAGE IF NO T READY

OCT 4r"3 7
OCT 2<~UHl
,246
.17?.

J

J

c
c

C

WRITE ON TAPE

C

1

15 BUFFER ICDB

SELECT TAPE UNIT
248 LA

/

1

1

15

3 fl~\:'! 1

OCT 5414
OCT 1514
INCREME NT I RE C BY 1 AND TEST TO SEE IF DON E
'l7
IREC
LA NREC
11
!REC

C

ocr

274Ul
• 2 03
401 DO 407 KK=1 1

J

4 ~7

c

PRINT RUN

C

c

40 2

1~0~0

OCT 2 74<l0
CALL Q~10 N (15)
IPTS=IREC•SPI
!NFORMATIO~

0~

LINE PHIN TER

WRITE(6 1 4~2)IFILE,IRU~A,IPTS,IREC
FO~MAT(9H

FILE N0,!4 , 5X3HRUNIS , I8 , 8H SA MPLESIB,SH RECORDS/)

J

,10

501 CALL OMON(15)
CALL QMO~I (14)
STOP
END

Appendix C
Programs to Access IMSL Program, FTFREQ, to Print Results , and to Take Averages of Several Spectra 1
MAR 22, 1978
17tl0lll LDG0~5554
I 7 1 0 2 2 BOT
1 7 I 0 22
I7
1 7:
I 7:
I7I

1 0 2'
I 0:2 'l
1 (I : 2 U
I 0 I 2 4 EOT

17:10:26 BOT
1 7:
17:
1 7:
1 7:

I 0 I 27
I 0 : 2 tl
1 (l: ~q
1 0: 29

17:10129 EUT

t7:10:"34 BllT
1 7: I 0: 3 o
I 7: I 0 1 35
1 7: I 0: 35

171 10:35
17:10t36 EOT

5555
5555
5555
5555
5555
5">55

Cl35,

J/CJ

MCSI I

SIGN ON BY NEW LOG ON

"CA NO E ~RITE~". (~ROCESS)
FJND
F, ICHUCKPROCESS,, KJ ND:PK6U 1 MYUSE:INl
OPEN
OUTFILE , I OU TFILE,,KlND:LP,MYUSE:OUT)
BLKf)(JT 0UTF!LE,I OU 1~1LE.,SF; O ,SL KS Z=22,MRECSZ=2?,U NI TS:WDSl
BLKEXIT F, (CH UC~PRnCESS ,,SF=3 0 , 8L"'SZ :U2U,HRECSZ;10,U N ITS= WD Sl
0,488 SEC CP U, 1, 0 18 SEC 10, KWSEC MEMt DA TA: 3,784 CODE: I 7 • 761
AVERAGE ME~t DATA : 2513 CODE : 11794 WORDS

5557
"CANDE ~RITER", IPR~C~SS)
5557 FI NO
F,CSPEC10UT,,KIN D:P~b4 ,~YUSE:I N)
5S57 OF~N
0 U H I L E , I l' 11 TF l L f. , , K I,._ 0: L P, 1'1 YUSE: 0 UTl
5557 BLKEX lT OUTF!LE ,( UU TFI LE ,,S~: O ,BL KSZ:22 , MRECS Z:22,UNITS:~OS)
55':>7 oLKf.XIT F • (spEc 1 0 lJ T • I sF= 3 0' eLKs z =~ 2 0, Mfl Ecs z=1 q, urJ I Ts =;I{) s)
5557
0,~67 SEC CPU, 0 , '1 11 SEC 10, K"'SEC MEHt DATA : 3,654 CODE
AVEk-GE ME M: D6TA : 2651 CODE : 11795 WORD S

= !6,255

55':>11
"CANOE ~~IlER" , (PROCESS)
5558 FJ ND
F , csPE r. 1 c r111 o• , K 1 No =P K 6 o , 11 y u SE =I N )
555 8 OPEN
OUTFILE,C uU TFJLE,, KIND :LP, MYUSE :OUT)
5558 BLKEliiT OUTFILE,CO U TFILE,,sF:O,BLKSZ=2~,MHECSZ=22,UNITS:WDSl
5556 BL~'>EXIT F,(~PECTC OM 8,,SF:30,BLKSZF420,MRECSZ:14,UNITS:WDS)
SSSB
0,4U8 SEC CPU, 0,768 SEC )O, KWSEC MEM t DATA : 3,099 CODE :
AVE~AGE ~EHI OAlA : 2548 COUE :
11796 WORDS

17:10:39 LOGOF5554

ESTIMATED
CP U TIME

ORIGINATING LSNI 6

CHARG~

1I~1 E

FOR 86700 USAG E
1,40 SECS
2,7 0 SECS

CARDS REAll

*** TOTAL COST :

PROC,

0

: 0,000 SEC, HEM: VIR, : 0,000 KW/SEC

TI~E

~

$
.f,

0,07 f1E~ORY
0,11 LI NES PRINTED
0 ,00 CARDS PUNC~ED

1~.34b

SIGN OFF · BY NORMAL LOG•OFF

513,'10 KW-SEC
187
0

$
.$
$

0,07
0 • 11
0,00

~0,36

1
Raw data llad previously been transformed from octal to decimal numbers and had been translated
into a format compatible with the Burroughs 6700 Computer. Programmer was Mr. Michael R.
Stephenson, Utah State University Computer Center.

m

CHUC ~ PR O CESS

10 0
i.' Otl
~ 00

uoo

5r10 PM wEDNE SDAY , MARCH 22r

(0~/ 0Q /7 8 )

SSEl AU TO R! ND
\ ~ I NU :
FRU M ! MSL/:
FIL E 131 K1~n = O IS • , M A, NE CS!ZE=151rHLOC KS !ZE:ISI,A AEASl
•
TIT LE =' S?t Cl RUMOUT , ")

11

7 00

FILE
FTLE
FILE

tlOO

fiLE

o1 KIN0 : ?R!NTEA)

'1 00
1 000

FILE

51•l ~O = O IS•,TIIL f =" PlRIME1EPS," o FILE1YPEc8)
~ 1 ( b 0 0 ) 1 2 ( 0 11 ) , I tJ D ( 6) 1 X I ND ( 2) 1 0 MV ( b ) 1

'5 00
b 0 II

I~I~n: D J SK ,TilL F =" k TITLES."rflL~lYPE= S l

121K!N0:0l~~.lllLE:"STITLES,",FILE1YPE•8)

>

0 I i1[I~ 5 I UN

o

10 10

xFf~(o0 lrC DHER (3 0 ),xY MV?( o l , PS2 (3 0 ),

11 i1 0
12 uO

1-'T IT L 5 I 2 q ll l , S T 11 L S 12 q n l , P Tl TL I? l , S TJ 1 L ( 2)

1 3 tlll
I U0 0
15 00
1o 0 tl
11 <1<1
1 'lOll

lE:t, AREAS: 2,

IOI K!NO : DJ S ~ ,F!L t TY PE:6 )

ACV ( 5 B) ,

F~ E~ I3 0l ,PSib O ),X CQ~ ('5 9) ,X SPEC 1(b O) ,AMPHAS(b 0 ) 1

(lATA

r

1 oOI.l 1 0 1 2~,0,0 /,n NDI , I\l 7l 1 0/

I N0 / 0

~EAD(l! , 3 0 ) R1!1L~

RHD (\ 2,3n l SlllL S
3 0 F iJ "' MAT(\ OH> )
RE10(5 , 100,E~Uc99) l CH A N riR UN ,L! M !T

10

00000100
00000200
00000300
00000400
0 0000 50 0
00 000 600
00000 7 00
00000800
0000 0 9 00
00001000
0000 1 010
00001100
00 00 1200
0000130 0
OOOOIUOO
0000 15 00
00001b00
0000 17 00

1 0 0 F 0 K IH 1 ( I 1 r 2 0)

ooon 1eoo

1~ 0 0

ILO•=ICtll'<

2 llull
21 00

I rr I GH

0000 19 00
00002000
00002\00

noo

IFITC rl•~.~~ .3) GO

22 11)
2220
23 00
2" 00
2 'iiJ

r)

=I C H • N

(f((! ChAN ,L l,1) , 0R ,(!C HAN ,G1,3llGO TO q q q

TO

Il

I: I, 2

II

STI1Ll1)=STilLSI2•1~< 1N +T•2l

CMANGEI1~,111LE=STITL)

2 ~ 00

REIO(lO ,! O I,E~ D =98liX!II),t2(1)rl =1• LIH!T)

Cf1 • r r ~E110 ,TllL~= H TI TLl

2'1fll)

10 1

) 000
3 1 •l 0
3 2 •1 n
3300

98 r<<JHbl< = l -1

FO~ ''All2!ol

un 12 I=! Lil•. .J HI GH
fl f~EwCX Irl NO , X l N D,XYMV,ACV,FREQ,PS,XCOV,XSPECT r

CAL L

3711 0

i,Q

3 •1 0 0

11 (A L L

AII PH AS , Xf E P 1 C0 I• ~ R 1 If P )

~G1 4

4'11~

4'1 2 2
U'12o
5 uuo

TLI 1 2

FTFRE Q(X2rlNUrKIN OrJY Hv 2,AC V,F REg, PS2,XCOV,XSPECT,

AMi'H AS , XF E. k 1 COH ER, JER)

QOOO

4Q00
4 '1 I 0

000 0 3~00

1 NO ( 2) = ~<J .' 1~R
1F(l, Etl ,2J GO 1 0 1:3

35110
3 on 1>

U~00

00002210
000022 2 0
00002300
0 000 24 00
00002500
000021>00
00002 7 00
00002800
00002 9 00
0000 ] 000
00003100

~T lTL(I): R TITLSI2•1R UN +T•2l

2 0 I) il
2 7 00

41on
4 200
4?10
u3nn
44 00
441 0
45 '10
4biJ0
U]OO

oooo noo

\~

I L[lcr : I
I rl I Grr= 2
l S no

12 CO NTI NUE

•R ITE I!],
\ 02

1 1R U N rLI H JT, NU~AR 1 XYMV (1),XYM V 2(I)rXYMV(2) 1
1 ( P 5(J),PS2(J),J :l,] P )

l02)!CHA N

XYM~2(2 )

F ORMA T( l 1r313 1 ~4f\U ,7 )

LOCK 13
CLOSU 1 0 )
wP I T E I b , I 0 3 l I CliAr; 1 I RUN r L I ~

l lt J FQPI ' Al(//1'

I

T r NU"1 ~ R

PARA~ETtRS SPEC IFIED WEH EI'/ 1 CHA NN EL: 'rl1/
1, 131,1 ""~r;ER ur· POI NTS r.u~u£ STE D
',r31

• RIJ" ~ . u••bf. ~
I NuH~fp OF P O ! ~
OU 14 l=IL O•,Jri)Gf<
!F(I,E u ,IJ GO TO 1 4
DD t o J=1,30
16 PS(J)•PS2(J)
0D t7J=I,2
\7

TS

US~D

:

1 , 13)

KVM ~(J)z AY~V 2(J)

14 •f<IH(o,10U)1

1

1978

XVMV(I),ni'1V(2)r

=

000033 00
000035 0 0
000031> 00
0000 37 00
000 0 3'1 00
00004000
000\14100
00004200
00 004 210
0000 43 00
00004400
00004410
00004500
00004600
00004700
00004800
00004'100
0000491 0
000 0 4'1(4
00004918
00004'122
00004926
00005 000

0'1
N

63

coooocoooco
O O C O O O O : : > O •';:)o

_.f'\l,.....:::llf'I..O,.._coa-c~l/'llf\ ~lf'\ .n ll"''.}'llf'\..0.0

oocooooooco

OCOOO~C"-=>00..:>

oc.oooccoooo
000000 0

"' '
"'
...,. ~"'
•W
..., - 0.._
. "'
a_ ,...,
0

0000

VJ

0

z

=>
0
<Xl

..._
0

>--

.- z
""
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u
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z
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~ 0 uJ 0 l.('l ·l.. - a..
u...:J...Q.U..
Cl.C
..::J
.... ,:) .:£ <.&...0 -

1

._ V)

)<)-

c

0'1.1'1

t

0

co-c:::>a-::
l

l.!:l o-- ~o- w

oc.oc o cccc co
O=:lOCC::::c-=-co,;:)

_ f'\J ,.,.. .::J'Ifl.O ,..... vo-o -

U"\U"\ V"lU"' U"ll.f'\ll'll/'IU" -CJ-C)

5110 PM

SPECT OU T ( 0 310'1/78)
300
u i) ()
1 00

FILE
FILE

.'\0 I)

FIL~

'lOO

FIL E

13lKIN O : D lS~,"41~ECS!ZE:15iobLDCK~IZE:15loA~EASIZE:!o•REAS:2,

TJTLE="SP EC1RUMUU1 , 1 )
12l KI NO : UJS Ko TI ILF ="STITLE S ,",FIL EIYPE:R )
ol K P!Il :P k i NT E~l
~~~Ih 0 :DI S K,TITLE:"SPAWA~,•,FILE1YP E :8)

! II Oil
l'::> <Jil

DIME~S!OM

161) (1
1711 0

30

I

FS(30loPS2(30loCYMV(2) 1 XYMV2(2),STJTLS(29Cl,ST!TLI2)

f. (A ll l I i o 3 0 ) S I I 1 L S

teoo
1'100

IL O ~=ICrlA N

2000

I

21 00
2200
2 21 0

IFCCIC HAN ,LT,1l,U A,C!CHA N,GT,3llGO TO 999
IFC!C HAN , ~ E,3lG O TO 15

2220

I"'IG-<•2
1 S OU 11 I: 1, 2
11 S TITL(I):STITLSI2•l ~UN tl•2)
CHA .~ Gt ( 1 3 , T I TL E: 5 T I I L l
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Appendix 0
Typical Output of Power Spectra 1
THE

NUMSER

OF RUNS C0 !-18 I !'J E[) IS

1 ; CHANNEL 2

2 ; CHANNEL 1
3: CHAt·mEL 2 4 : CH A~JN E: L 1
5: l HAt-Jt~ EL 2
b: C~Ai~NEL 1

FREQ
3,02
l.I,03
S,Oi.l

6,05
7,06

8. (1 7
9,07
10,08
11 • 0 q
1 2. l 0
13 • 1 1
1£1,12
1 s. 12
1 6. 1 3
17.1iJ
1 8. 1 5
1 q. 1 6

RUN

# 1 !3
RIJrj u l 15
RUrJ tt 125
RUr·;
127
RUN 1: 137

...

RUN

1

t55498LJ~t00

,12682781:+00
.ll1Ll2i.I7E+OO
• 7480361F.: .. Ol
,5?.371 1~5E .. 01
,IH)i3860?.~·01

,3el77:Jrtt.·Ol
,31.l12U81E-01
,2 80q261~-01

,2276624£•01
,2059760E•01
.1 B'1 3564f.•Ol
,15 555 t7E ... 01
,1 i.L~6732f • O l

,l:3S706t'E·01
,121?.e9t-E-Ol

,11i1?.477E•01
,108o811~-01

2 3, I 9

, 7 6 ~· 9 2 7 b r: • I) 2
,71 P~765E•0?

26,21.

27,22
28,23
2q,2lJ

139

,1 V18009t+OO

2 1 • 17
22.18
25.21

#

!\JOPM, P,S,

2 0. 1 7

?.lJ,2U

6

,93LJ73~2t.•\12

,o853973E•02
,65/.j2724E•02

.S77070tJ E•02
,5f.j0718f•02
.57 (166171=.•02

AVERAGE :

. 6S0036tE+Ol

1In this case the column under the heading NORr~ . P.S. represents
the averaged va l ues for six power spectra which had previously been
"normalized" so that total power in the range from 3.02 Hertz to 29.24
Hertz was scaled to unity.
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